Catch up on the most well-viewed radiology video interviews from Diagnostic Imaging in September 2026.

Catch up on the top radiology content of the past week.

Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.

In a new podcast episode, Amir Iravani, MD, FRACP, discusses emerging dosimetry data from the COMPETE trial for 177Lu-edotreotide and how it may help facilitate more personalized treatment for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Catch up on the top radiology content of the past week.

Artificial intelligence plaque analysis of CCTA scans showed that 27 percent of former NFL players had severe or extensive total plaque volume, according to a new study to be presented at the American Heart Association Scientific Sessions 2026 this week.

While the P4 trial represents a landmark study on the use of CCTA guidance for percutaneous coronary intervention (PCI), there are pertinent caveats that warrant closer inspection.

While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.